17-61680480-C-CTTTCT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS1BS2
The NM_032043.3(BRIP1):c.*2815_*2816insAGAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0052 ( 23 hom., cov: 0)
Consequence
BRIP1
NM_032043.3 3_prime_UTR
NM_032043.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0550
Publications
0 publications found
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
- familial ovarian cancerInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Fanconi anemiaInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- Fanconi anemia complementation group JInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary breast carcinomaInheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- colorectal adenomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00517 (642/124070) while in subpopulation AFR AF = 0.0168 (532/31740). AF 95% confidence interval is 0.0156. There are 23 homozygotes in GnomAd4. There are 315 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AD,AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRIP1 | ENST00000259008.7 | c.*2815_*2816insAGAAA | 3_prime_UTR_variant | Exon 20 of 20 | 1 | NM_032043.3 | ENSP00000259008.2 | |||
BRIP1 | ENST00000682755.1 | c.*2815_*2816insAGAAA | 3_prime_UTR_variant | Exon 18 of 18 | ENSP00000507660.1 |
Frequencies
GnomAD3 genomes AF: 0.00515 AC: 639AN: 124094Hom.: 23 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
639
AN:
124094
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00517 AC: 642AN: 124070Hom.: 23 Cov.: 0 AF XY: 0.00538 AC XY: 315AN XY: 58552 show subpopulations
GnomAD4 genome
AF:
AC:
642
AN:
124070
Hom.:
Cov.:
0
AF XY:
AC XY:
315
AN XY:
58552
show subpopulations
African (AFR)
AF:
AC:
532
AN:
31740
American (AMR)
AF:
AC:
66
AN:
11378
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3230
East Asian (EAS)
AF:
AC:
2
AN:
4134
South Asian (SAS)
AF:
AC:
2
AN:
3944
European-Finnish (FIN)
AF:
AC:
5
AN:
5350
Middle Eastern (MID)
AF:
AC:
2
AN:
200
European-Non Finnish (NFE)
AF:
AC:
22
AN:
61624
Other (OTH)
AF:
AC:
11
AN:
1626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Fanconi anemia Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Breast neoplasm Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.